---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-235251"
form_type: "8-K"
ticker: "VCNX"
cik: "0001205922"
company_name: "VACCINEX, INC."
filed_at: "2024-10-09T23:59:59+00:00"
generated_at: "2026-05-30T17:08:45.151916+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Vaccinex receives Nasdaq delisting notice for failing equity standard; will appeal

## Summary
- Company failed to meet Nasdaq's minimum $2.5M stockholders' equity requirement for continued listing.
- Nasdaq granted extension until Sept 30, 2024, to regain compliance; company did not comply.
- On Oct 7, 2024, Nasdaq determined to delist unless company timely appeals to a Hearings Panel.
- Company intends to appeal, which automatically stays suspension and delisting pending Panel decision.
- No assurance that Hearings Panel will grant continued listing or that compliance will be achieved.

## SEC filing metadata
- accession: 0001193125-24-235251
- form_type: 8-K
- ticker: VCNX
- cik: 0001205922
- company_name: VACCINEX, INC.
- filed_at: 2024-10-09T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1205922/000119312524235251/0001193125-24-235251-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1205922/000119312524235251/d851320d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-235251
- JSON: https://secwatch.observer/filing/0001193125-24-235251.json
- Plain text: https://secwatch.observer/filing/0001193125-24-235251.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.